MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 191 filers reported holding MYRIAD GENETICS INC in Q1 2020. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,581,000 | -60.0% | 351,837 | -58.0% | 0.32% | -62.2% |
| Q3 2019 | $23,982,000 | +1.2% | 837,648 | -1.8% | 0.86% | +8.8% |
| Q2 2019 | $23,707,000 | -21.1% | 853,379 | -5.7% | 0.79% | -18.5% |
| Q1 2019 | $30,043,000 | +29.1% | 904,913 | +13.0% | 0.97% | +13.9% |
| Q4 2018 | $23,272,000 | +44.5% | 800,553 | +52.1% | 0.85% | -8.4% |
| Q2 2016 | $16,101,000 | +1127.2% | 526,184 | +741.5% | 0.93% | +875.8% |
| Q4 2013 | $1,312,000 | +143.4% | 62,526 | +172.6% | 0.10% | +82.7% |
| Q3 2013 | $539,000 | -29.8% | 22,934 | -19.8% | 0.05% | -31.6% |
| Q2 2013 | $768,000 | – | 28,589 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |